A human plasma-derived Factor X concentrate has been developed and approved for the treatment of bleedings in people with Hereditary Deficit of coagulation factor X, an ultra-rare disease.
Access to the medicine may vary depending on the country in Europe.
This website contains some information about Factor X deficit of coagulation. The information provided on this page is provided for educational purposes only and is not intended to replace discussions with healthcare professionals (doctor or pharmacist).
If you have any questions about your condition, please contact your Doctor or Pharmacist.
If you are in Europe and have been prescribed Coagadex, a plasma-derived blood coagulation factor X concentrate, by your Healthcare Professional click here.
Coagadex® Package Leaflet
If you are a patient who has been prescribed Coagadex® get access to the Package leaflet in the European Union here.
Always read the instructions on the provided package leaflet carefully.
Other Health information within this website is provided for educational purposes only and is not intended to replace discussions with healthcare professionals (doctor or pharmacist)
Reporting of side effects: If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in the package leaflet.
By reporting side effects you can help provide more information on the safety of this medicine.